With increasing life viagr|cials expectancies, improved surgical tools, and better information on patient results, many older men diagnosed with early {prostate|viagra}
Alprostadil is a drug that has been available for the treatment for ED years before Vigra was even a twinkle viagr in the eyes of the pharmacologists at Pfizer. Yet alprostadil has all but disappeared as a front line treatment for ED, this is despite the fact that some clinical trials indicate that alprostadil is as effective as Viagra&
Therefore, to cash in Vigra on this huge and relatively new market, (at least in terms of its acceptance), it is no surprise to discover viagr that numerous pharmaceutical companies are rushing to find new drugs and new methodology, to treat this sexual disease that is clearly an age-related disorder.
174;), the market for treatments for erectile dysfunction has grown to become worth about $2 billion viagr worldwide per annum. That is now projected to grow to $4 billion per year by the year 2004 and to an Vigra astonishing $6 billion per year by 2006!
That is the subject Vigra of this article, we shan’t get too bogged down in the psychology of impotence, or the social or economic impacts of such a "disease" and its treatments. What we shall concern ourselves with here are viagr the pharmacokinetics, uses, interactions, effects and properties of these revolutionary new approaches to erectile dysfunction.